{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T15:15:10Z","timestamp":1794582910377,"version":"4.9.1"},"reference-count":101,"publisher":"Walter de Gruyter GmbH","issue":"6","license":[{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Regional Innovation and Development Joint Fund of NSFC","award":["U22A20366"],"award-info":[{"award-number":["U22A20366"]}]},{"name":"The Anhui Provincial Department of Education Scientific Research Project","award":["2025AHGXZK40547"],"award-info":[{"award-number":["2025AHGXZK40547"]}]},{"name":"The Anhui Province Traditional Chinese Medicine Science and Technology Research Special Project","award":["202303a07020004"],"award-info":[{"award-number":["202303a07020004"]}]},{"name":"The Anhui Province Clinical Medical Research Translation Special Programme","award":["202204295107020066"],"award-info":[{"award-number":["202204295107020066"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Glycolysis is increasingly recognized as a pathological backbone in neurodegenerative diseases rather than merely an accompanying epiphenomenon. This article first delineates the division of metabolic labor among neurons, astrocytes, microglia, and oligodendrocytes in the brain, with particular emphasis on cell type\u2013specific glycolytic flux, lactate shuttling, and an integrated brain\u2013periphery framework of energy metabolism. It then systematically compares alterations in glucose uptake, glycolytic intermediates, and lactate metabolism across Alzheimer disease (AD), Parkinson disease (PD), amyotrophic lateral sclerosis (ALS), Wilson disease (WD), Huntington\u2019s disease (HD), and multiple sclerosis (MS), highlighting pronounced heterogeneity across cell types, disease stages, and brain regions. These metabolic disturbances encompass not only global cerebral hypometabolism and an energy crisis, but also compensatory hyperglycolysis and inflammation-associated metabolic reprogramming in astrocytes and microglia, and extend further to systemic metabolic phenotypes involving peripheral blood cells, muscle, and liver. The article summarizes recent methodological advances for characterizing glycolytic reprogramming, including fluorodeoxyglucose positron emission tomography (FDG-PET), hyperpolarized carbon-13 magnetic resonance spectroscopy(\u02c613C-MRS), metabolomics, single-cell and spatial transcriptomics, genetically encoded metabolic sensors, and Seahorse assays. In addition, potential therapeutic strategies are discussed, focusing on targets such as 6-phosphofructo-2-kinase\/fructose-2,6-bisphosphatase 3(PFKFB3), the astrocyte\u2013neuron lactate shuttle (ANLS), microglial glycolysis and lactylation, as well as systemic metabolic modulation and nanodelivery approaches. Finally, key challenges are highlighted, including unclear causal relationships, biphasic and cell type\u2013specific effects, insufficient brain\u2013periphery integration, and the lack of standardized metrics, underscoring the need for longitudinal, multimodal, and stage-specific strategies to reposition glycolysis as a targetable therapeutic dimension in neurodegenerative diseases.<\/jats:p>","DOI":"10.1515\/revneuro-2026-0037","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T22:01:09Z","timestamp":1777327269000},"page":"577-591","source":"Crossref","is-referenced-by-count":2,"title":["Glycolysis as a central pathological axis in neurodegenerative diseases"],"prefix":"10.1515","volume":"37","author":[{"given":"Ting","family":"Cheng","sequence":"first","affiliation":[{"name":"The First Affiliated Hospital of Anhui University of Chinese Medicine , 230031 , Hefei , China"},{"name":"Brain Disease Research Institute, Anhui University of Chinese Medicine , 230031 , Hefei , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingwei","family":"Li","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Anhui University of Chinese Medicine , 230031 , Hefei , China"},{"name":"Brain Disease Research Institute, Anhui University of Chinese Medicine , 230031 , Hefei , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulong","family":"Yang","sequence":"additional","affiliation":[{"name":"Anhui University of Chinese Medicine , 230038 , Hefei , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Rao","sequence":"additional","affiliation":[{"name":"Anhui University of Chinese Medicine , 230038 , Hefei , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenming","family":"Yang","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Anhui University of Chinese Medicine , 230031 , Hefei , China"},{"name":"Brain Disease Research Institute, Anhui University of Chinese Medicine , 230031 , Hefei , China"},{"name":"Key Laboratory of XinAn Medicine, Ministry of Education , 230038 , Hefei , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,4,23]]},"reference":[{"key":"2026080410023542744_j_revneuro-2026-0037_ref_001","doi-asserted-by":"crossref","unstructured":"Afridi, R., Rahman, M.H., and Suk, K. (2022). Implications of glial metabolic dysregulation in the pathophysiology of neurodegenerative diseases. Neurobiol. Dis. 174: 105874, https:\/\/doi.org\/10.1016\/j.nbd.2022.105874.","DOI":"10.1016\/j.nbd.2022.105874"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_002","doi-asserted-by":"crossref","unstructured":"Alhasan, M.S., Alhasan, A.S., Milburn, J., Khalil, M., Almaghraby, A., Alharthi, O., Hamoud, S., Essibayi, M.A., Elhassan, Y.H., Feltrin, F., et al.. (2025). FDG-PET brain glucose hypometabolism predicts Alzheimer\u2019s disease progression pathways in cognitively normal adults: a longitudinal competing risks modeling. Metabol. Open 28: 100400, https:\/\/doi.org\/10.1016\/j.metop.2025.100400.","DOI":"10.1016\/j.metop.2025.100400"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_003","doi-asserted-by":"crossref","unstructured":"Beard, E., Lengacher, S., Dias, S., Magistretti, P.J., and Finsterwald, C. (2021). Astrocytes as key regulators of brain energy metabolism: new therapeutic perspectives. Front. Physiol. 12: 825816, https:\/\/doi.org\/10.3389\/fphys.2021.825816.","DOI":"10.3389\/fphys.2021.825816"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_004","doi-asserted-by":"crossref","unstructured":"Bekdash, R., Quejada, J.R., Ueno, S., Kawano, F., Morikawa, K., Klein, A.D., Matsumoto, K., Lee, T.C., Nakanishi, K., Chalan, A., et al.. (2021). GEM-IL: a highly responsive fluorescent lactate indicator. Cell Rep. Methods 1: 100092, https:\/\/doi.org\/10.1016\/j.crmeth.2021.100092.","DOI":"10.1016\/j.crmeth.2021.100092"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_005","doi-asserted-by":"crossref","unstructured":"Bell, S.M., Burgess, T., Lee, J., Blackburn, D.J., Allen, S.P., and Mortiboys, H. (2020). Peripheral glycolysis in neurodegenerative diseases. Int. J.\u00a0Mol. Sci. 21, https:\/\/doi.org\/10.3390\/ijms21238924.","DOI":"10.3390\/ijms21238924"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_006","doi-asserted-by":"crossref","unstructured":"Bj\u00f6RKQVIST, M. (2023). Centrally and peripherally altered glucose transporters: is it time to revisit energy deficiency as a potential treatment strategy in Huntington\u2019s disease? EBioMedicine 98: 104882, https:\/\/doi.org\/10.1016\/j.ebiom.2023.104882.","DOI":"10.1016\/j.ebiom.2023.104882"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_007","doi-asserted-by":"crossref","unstructured":"Bl\u00e1ZQUEZ, E., Hurtado-Carneiro, V., Lebaut-Ayuso, Y., Vel\u00e1ZQUEZ, E., Garc\u00edA-Garc\u00edA, L., G\u00f3MEZ-Oliver, F., Ruiz-Albusac, J.M., \u00c1vila, J., and Pozo, M. (2022). Significance of brain glucose hypometabolism, altered insulin signal transduction, and insulin resistance in several neurological diseases. Front. Endocrinol. 13: 873301, https:\/\/doi.org\/10.3389\/fendo.2022.873301.","DOI":"10.3389\/fendo.2022.873301"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_008","doi-asserted-by":"crossref","unstructured":"Bola\u00f1OS, J.P. and Magistretti, P.J. (2025). The neuron-astrocyte metabolic unit as a cornerstone of brain energy metabolism in health and disease. Nat. Metab 7: 2414\u20132423.","DOI":"10.1038\/s42255-025-01404-9"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_009","doi-asserted-by":"crossref","unstructured":"Bonvento, G. and Bola\u00f1OS, J.P. (2021). Astrocyte-neuron metabolic cooperation shapes brain activity. Cell Metab. 33: 1546\u20131564, https:\/\/doi.org\/10.1016\/j.cmet.2021.07.006.","DOI":"10.1016\/j.cmet.2021.07.006"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_010","doi-asserted-by":"crossref","unstructured":"Brier, M.R., Judge, B., Ying, C., Salter, A., An, H., Patel, A., Wang, Q., Wang, Y., Cross, A.H., Naismith, R.T., et al.. (2025). Increased white matter aerobic glycolysis in multiple sclerosis. Ann. Neurol. 97: 766\u2013778, https:\/\/doi.org\/10.1002\/ana.27165.","DOI":"10.1002\/ana.27165"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_011","doi-asserted-by":"crossref","unstructured":"Cal\u00ec, C., Cantando, I., Veloz Castillo, M.F., Gonzalez, L., and Bezzi, P. (2024). Metabolic reprogramming of astrocytes in pathological conditions: implications for neurodegenerative diseases. Int. J.\u00a0Mol. Sci. 25, https:\/\/doi.org\/10.3390\/ijms25168922.","DOI":"10.3390\/ijms25168922"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_012","doi-asserted-by":"crossref","unstructured":"Chandrasekaran, A., Dittlau, K.S., Corsi, G.I., Haukedal, H., Doncheva, N.T., Ramakrishna, S., Ambardar, S., Salcedo, C., Schmidt, S.I., Zhang, Y., et al.. (2021). Astrocytic reactivity triggered by defective autophagy and metabolic failure causes neurotoxicity in frontotemporal dementia type 3. Stem. Cell Rep. 16: 2736\u20132751, https:\/\/doi.org\/10.1016\/j.stemcr.2021.09.013.","DOI":"10.1016\/j.stemcr.2021.09.013"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_013","doi-asserted-by":"crossref","unstructured":"Chang, C.P., Wu, C.W., and Chern, Y. (2024). Metabolic dysregulation in Huntington\u2019s disease: neuronal and glial perspectives. Neurobio.l Dis. 201: 106672, https:\/\/doi.org\/10.1016\/j.nbd.2024.106672.","DOI":"10.1016\/j.nbd.2024.106672"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_014","doi-asserted-by":"crossref","unstructured":"Chen, S., Cao, Z., Nandi, A., Counts, N., Jiao, L., Prettner, K., Kuhn, M., Seligman, B., Tortorice, D., Vigo, D., et al.. (2024). The global macroeconomic burden of Alzheimer\u2019s disease and other dementias: estimates and projections for 152 countries or territories. Lancet Glob. Health 12: e1534\u2013e1543, https:\/\/doi.org\/10.1016\/s2214-109x(24)00264-x.","DOI":"10.1016\/S2214-109X(24)00264-X"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_015","doi-asserted-by":"crossref","unstructured":"Chen, W.T., Lu, A., Craessaerts, K., Pavie, B., Sala Frigerio, C., Corthout, N., Qian, X., Lal\u00e1KOV\u00e1, J., K\u00fcHNEMUND, M., Voytyuk, I., et al.. (2020). Spatial transcriptomics and in\u00a0situ sequencing to study Alzheimer\u2019s disease. Cell 182: 976\u2013991.e19, https:\/\/doi.org\/10.1016\/j.cell.2020.06.038.","DOI":"10.1016\/j.cell.2020.06.038"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_016","doi-asserted-by":"crossref","unstructured":"Chen, L., Wang, C., Qin, L., and Zhang, H. (2025). Parkinson\u2019s disease and glucose metabolism impairment. Trans. Neurodegener. 14: 10, https:\/\/doi.org\/10.1186\/s40035-025-00467-8.","DOI":"10.1186\/s40035-025-00467-8"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_017","doi-asserted-by":"crossref","unstructured":"Coelho, P. and Rego, A.C. (2024). Chapter 16 - glucose, glycolysis, and neurodegenerative disorders. In: Ferreira, R., Oliveira, P.F., and Nogueira-Ferreira, R. (Eds.). Glycolysis. Academic Press.","DOI":"10.1016\/B978-0-323-91704-9.00012-4"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_018","doi-asserted-by":"crossref","unstructured":"Dev, S., Kruse, R.L., Hamilton, J.P., and Lutsenko, S. (2022). Wilson disease: update on pathophysiology and treatment. Front. Cell Dev. Biol. 10: 871877, https:\/\/doi.org\/10.3389\/fcell.2022.871877.","DOI":"10.3389\/fcell.2022.871877"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_019","doi-asserted-by":"crossref","unstructured":"Dong, R., Denier-Fields, D.N., Lu, Q., Suridjan, I., Kollmorgen, G., Wild, N., Betthauser, T.J., Carlsson, C.M., Asthana, S., Johnson, S.C., et al.. (2022). Principal components from untargeted cerebrospinal fluid metabolomics associated with Alzheimer\u2019s disease biomarkers. Neurobiol. Aging 117: 12\u201323, https:\/\/doi.org\/10.1016\/j.neurobiolaging.2022.04.009.","DOI":"10.1016\/j.neurobiolaging.2022.04.009"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_020","doi-asserted-by":"crossref","unstructured":"Dong, J., Gao, Z., Liu, M., Qian, B., Yuan, C., Liu, H., Rao, N., and Liu, Y. (2025). Astrocyte-neuron metabolic synergies in neurological homeostasis and disease. Neurochem. Res. 50: 293, https:\/\/doi.org\/10.1007\/s11064-025-04548-y.","DOI":"10.1007\/s11064-025-04548-y"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_021","unstructured":"European Association for the Study of the Liver (2025). EASL-ERN clinical practice guidelines on Wilson\u2019s disease. J.\u00a0Hepatol."},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_022","doi-asserted-by":"crossref","unstructured":"Fang, M., Zhou, Y., He, K., Lu, Y., Tao, F., and Huang, H. (2025). Glucose metabolic reprogramming in microglia: implications for neurodegenerative diseases and targeted therapy. Mol. Neurobiol. 62: 8204\u20138221, https:\/\/doi.org\/10.1007\/s12035-025-04775-y.","DOI":"10.1007\/s12035-025-04775-y"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_023","doi-asserted-by":"crossref","unstructured":"Ferreira, I.L., Cunha-Oliveira, T., Nascimento, M.V., Ribeiro, M., Proen\u00e7A, M.T., Janu\u00e1RIO, C., Oliveira, C.R., and Rego, A.C. (2011). Bioenergetic dysfunction in Huntington\u2019s disease human cybrids. Exp. Neurol. 231: 127\u2013134, https:\/\/doi.org\/10.1016\/j.expneurol.2011.05.024.","DOI":"10.1016\/j.expneurol.2011.05.024"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_024","doi-asserted-by":"crossref","unstructured":"Firbank, M.J., Yarnall, A.J., Lawson, R.A., Duncan, G.W., Khoo, T.K., Petrides, G.S., O\u2019Brien, J.T., Barker, R.A., Maxwell, R.J., Brooks, D.J., et al.. (2017). Cerebral glucose metabolism and cognition in newly diagnosed Parkinson\u2019s disease: ICICLE-PD study. J.\u00a0Neurol. Neurosurg. Psych. 88: 310\u2013316, https:\/\/doi.org\/10.1136\/jnnp-2016-313918.","DOI":"10.1136\/jnnp-2016-313918"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_025","doi-asserted-by":"crossref","unstructured":"Fletcher, J.L. and Young, K.M. (2024). Do oligodendrocytes regulate axonal glucose uptake and consumption? Trends Neurosci. 47: 569\u2013570, https:\/\/doi.org\/10.1016\/j.tins.2024.06.001.","DOI":"10.1016\/j.tins.2024.06.001"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_026","doi-asserted-by":"crossref","unstructured":"Gao, R., Gao, Y., Su, W., and Wang, R. (2025). Decoding microglial polarization and metabolic reprogramming in neurodegenerative diseases: implications for disease progression and therapy. Aging Dis.","DOI":"10.14336\/AD.2024.1629"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_027","doi-asserted-by":"crossref","unstructured":"Garrett, L.R. and Niccoli, T. (2022). Frontotemporal dementia and glucose metabolism. Front. Neurosci. 16: 812222, https:\/\/doi.org\/10.3389\/fnins.2022.812222.","DOI":"10.3389\/fnins.2022.812222"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_028","doi-asserted-by":"crossref","unstructured":"Gautam, P., Yadav, R., Vishwakarma, R.K., Pathak, A., and Singh, C. (2025). Metabolic dysregulation in amyotrophic lateral sclerosis: insights from (1)H NMR-based metabolomics in a tertiary care center in India. Metab. Brain Dis. 40: 196, https:\/\/doi.org\/10.1007\/s11011-025-01616-8.","DOI":"10.1007\/s11011-025-01616-8"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_029","unstructured":"GBD 2019 Dementia Forecasting Collaborators (2022). Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the global burden of disease study 2019. Lancet Public Health 7: e105\u2013e125."},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_030","doi-asserted-by":"crossref","unstructured":"Ge, X., Zhu, Y., Xiong, J., Gu, Y., Wang, X., Ye, W., Wang, H., Gao, Y., Cai, W., Zhou, X., et al.. (2025). Metabolic reprogramming through histone lactylation in microglia and macrophages recruits CD8(+) T lymphocytes and aggravates spinal cord injury. Neuron 113: 2280\u20132296.e8, https:\/\/doi.org\/10.1016\/j.neuron.2025.04.003.","DOI":"10.1016\/j.neuron.2025.04.003"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_031","doi-asserted-by":"crossref","unstructured":"Gebhard, S., Ronimus, R.S., and Morgan, H.W. (2001). Inhibition of phosphofructokinases by copper(II). FEMS Microbiol. Lett. 197: 105\u2013109, https:\/\/doi.org\/10.1111\/j.1574-6968.2001.tb10590.x.","DOI":"10.1111\/j.1574-6968.2001.tb10590.x"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_032","doi-asserted-by":"crossref","unstructured":"Giacomello, G., Otto, C., Priller, J., Ruprecht, K., B\u00f6TTCHER, C., and Parr, M.K. (2023). 1,2-(13)C(2)-Glucose tracing approach to assess metabolic alterations of human monocytes under neuroinflammatory conditions. Curr. Issues Mol. Biol. 45: 765\u2013781, https:\/\/doi.org\/10.3390\/cimb45010051.","DOI":"10.3390\/cimb45010051"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_033","doi-asserted-by":"crossref","unstructured":"Gouarn\u00e9, C., Tardif, G., Tracz, J., Latyszenok, V., Michaud, M., Clemens, L.E., Yu-Taeger, L., Nguyen, H.P., Bordet, T., and Pruss, R.M. (2013). Early deficits in glycolysis are specific to striatal neurons from a rat model of huntington disease. PLoS One 8: e81528, https:\/\/doi.org\/10.1371\/journal.pone.0081528.","DOI":"10.1371\/journal.pone.0081528"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_034","doi-asserted-by":"crossref","unstructured":"Han, R., Liang, J., and Zhou, B. (2021). Glucose metabolic dysfunction in neurodegenerative diseases-new mechanistic insights and the potential of hypoxia as a prospective therapy targeting metabolic reprogramming. Int. J.\u00a0Mol. Sci. 22, https:\/\/doi.org\/10.3390\/ijms22115887.","DOI":"10.3390\/ijms22115887"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_035","doi-asserted-by":"crossref","unstructured":"HD iPSC Consortium (2020). Bioenergetic deficits in Huntington\u2019s disease iPSC-derived neural cells and rescue with glycolytic metabolites. Hum. Mol. Genet. 29: 1757\u20131771.","DOI":"10.1093\/hmg\/ddy430"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_036","doi-asserted-by":"crossref","unstructured":"Hochrein, S.M., Wu, H., Eckstein, M., Arrigoni, L., Herman, J.S., Schumacher, F., Gerecke, C., Rosenfeldt, M., Gr\u00fcN, D., Kleuser, B., et al.. (2022). The glucose transporter GLUT3 controls T helper 17 cell responses through glycolytic-epigenetic reprogramming. Cell Metab. 34: 516\u2013532.e11, https:\/\/doi.org\/10.1016\/j.cmet.2022.02.015.","DOI":"10.1016\/j.cmet.2022.02.015"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_037","doi-asserted-by":"crossref","unstructured":"Huang, Q., Wang, Y., Chen, S., and Liang, F. (2024). Glycometabolic reprogramming of microglia in neurodegenerative diseases: insights from neuroinflammation. Aging Dis. 15: 1155\u20131175, https:\/\/doi.org\/10.14336\/AD.2023.0807.","DOI":"10.14336\/AD.2023.0807"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_038","doi-asserted-by":"crossref","unstructured":"Jia, J., Zhao, S., Zhao, J., and Gao, Y. (2025). Engineered nanoparticles for the treatment of Alzheimer\u2019s disease. Front. Pharmacol. 16: 1510798, https:\/\/doi.org\/10.3389\/fphar.2025.1510798.","DOI":"10.3389\/fphar.2025.1510798"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_039","doi-asserted-by":"crossref","unstructured":"Joardar, A., Manzo, E., and Zarnescu, D.C. (2017). Metabolic dysregulation in amyotrophic lateral sclerosis: challenges and opportunities. Curr. Genet. Med. Rep. 5: 108\u2013114, https:\/\/doi.org\/10.1007\/s40142-017-0123-8.","DOI":"10.1007\/s40142-017-0123-8"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_040","doi-asserted-by":"crossref","unstructured":"Kelly, J., Moyeed, R., Carroll, C., Luo, S., and Li, X. (2023). Blood biomarker-based classification study for neurodegenerative diseases. Sci. Rep. 13: 17191, https:\/\/doi.org\/10.1038\/s41598-023-43956-4.","DOI":"10.1038\/s41598-023-43956-4"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_041","doi-asserted-by":"crossref","unstructured":"La Rocca, C., Carbone, F., de Rosa, V., Colamatteo, A., Galgani, M., Perna, F., Lanzillo, R., Brescia Morra, V., Orefice, G., Cerillo, I., et al. (2017). Immunometabolic profiling of T\u00a0cells from patients with relapsing-remitting multiple sclerosis reveals an impairment in glycolysis and mitochondrial respiration. Metabolism 77: 39\u201346, https:\/\/doi.org\/10.1016\/j.metabol.2017.08.011.","DOI":"10.1016\/j.metabol.2017.08.011"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_042","doi-asserted-by":"crossref","unstructured":"Le Bars, S. and Glaab, E. (2025). Single-cell cortical transcriptomics reveals common and distinct changes in cell-cell communication in alzheimer\u2019s and Parkinson\u2019s disease. Mol. Neurobiol. 62: 2655\u20132673, https:\/\/doi.org\/10.1007\/s12035-024-04419-7.","DOI":"10.1007\/s12035-024-04419-7"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_043","doi-asserted-by":"crossref","unstructured":"Le Douce, J., Maugard, M., Veran, J., Matos, M., J\u00e9GO, P., Vigneron, P.A., Faivre, E., Toussay, X., Vandenberghe, M., Balbastre, Y., et al.. (2020). Impairment of glycolysis-derived l-Serine production in astrocytes contributes to cognitive deficits in Alzheimer\u2019s disease. Cell Metab. 31: 503\u2013517 , https:\/\/doi.org\/10.1016\/j.cmet.2020.02.004.","DOI":"10.1016\/j.cmet.2020.02.004"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_044","doi-asserted-by":"crossref","unstructured":"Le Page, L.M., Guglielmetti, C., Taglang, C., and Chaumeil, M.M. (2020). Imaging brain metabolism using hyperpolarized (13)C magnetic resonance spectroscopy. Trends Neurosci. 43: 343\u2013354, https:\/\/doi.org\/10.1016\/j.tins.2020.03.006.","DOI":"10.1016\/j.tins.2020.03.006"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_045","doi-asserted-by":"crossref","unstructured":"Li, M., Shao, J., Guo, Z., Jin, C., Wang, L., Wang, F., Jia, Y., Zhu, Z., Zhang, Z., Zhang, F., et al.. (2020). Novel mitochondrion-targeting copper(II) complex induces HK2 malfunction and inhibits glycolysis via Drp1-mediating mitophagy in HCC. J.\u00a0Cell. Mol. Med. 24: 3091\u20133107, https:\/\/doi.org\/10.1111\/jcmm.14971.","DOI":"10.1111\/jcmm.14971"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_046","doi-asserted-by":"crossref","unstructured":"Llibre, A., Kucuk, S., Gope, A., Certo, M., and Mauro, C. (2025). Lactate: a key regulator of the immune response. Immunity 58: 535\u2013554, https:\/\/doi.org\/10.1016\/j.immuni.2025.02.008.","DOI":"10.1016\/j.immuni.2025.02.008"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_047","doi-asserted-by":"crossref","unstructured":"Lu, J., Feng, S., Liu, Z., Xiao, Y., Zhang, H., Wang, S., and Zhao, Q. (2025). Co-delivery of copper chelators and glycolytic inhibitors to disrupt glucose metabolism and inhibit tumor metastasis. Chem. Eng. J. 520: 165899, https:\/\/doi.org\/10.1016\/j.cej.2025.165899.","DOI":"10.1016\/j.cej.2025.165899"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_048","doi-asserted-by":"crossref","unstructured":"Lu, N., Jin, Z., Liu, N., Zhu, C., Wei, H., and Xu, Q. (2025). Microglial glycolytic reprogramming in Alzheimer\u2019s disease: association with impaired phagocytic function and altered vascular proximity. J.\u00a0Neuroinflammation 22: 223, https:\/\/doi.org\/10.1186\/s12974-025-03546-9.","DOI":"10.1186\/s12974-025-03546-9"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_049","doi-asserted-by":"crossref","unstructured":"M\u00e4CHLER, P., Wyss, M.T., Elsayed, M., Stobart, J., Gutierrez, R., von Faber-Castell, A., Kaelin, V., Zuend, M., San Mart\u00edN, A., Romero-G\u00f3MEZ, I., et al.. (2016). In vivo evidence for a lactate gradient from astrocytes to neurons. Cell Metab. 23: 94\u2013102, https:\/\/doi.org\/10.1016\/j.cmet.2015.10.010.","DOI":"10.1016\/j.cmet.2015.10.010"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_050","doi-asserted-by":"crossref","unstructured":"Manzo, E., Lorenzini, I., Barrameda, D., O\u2019Conner, A.G., Barrows, J.M., Starr, A., Kovalik, T., Rabichow, B.E., Lehmkuhl, E.M., Shreiner, D.D., et al.. (2019). Glycolysis upregulation is neuroprotective as a compensatory mechanism in ALS. Elife 8, https:\/\/doi.org\/10.7554\/elife.45114.","DOI":"10.7554\/eLife.45114"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_051","doi-asserted-by":"crossref","unstructured":"Mason, S. (2017). Lactate shuttles in neuroenergetics-homeostasis, allostasis and beyond. Front. Neurosci. 11: 43, https:\/\/doi.org\/10.3389\/fnins.2017.00043.","DOI":"10.3389\/fnins.2017.00043"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_052","doi-asserted-by":"crossref","unstructured":"Mathur, D., L\u00f3PEZ-Rodas, G., Casanova, B., and Marti, M.B. (2014). Perturbed glucose metabolism: insights into multiple sclerosis pathogenesis. Front. Neurol. 5: 250, https:\/\/doi.org\/10.3389\/fneur.2014.00250.","DOI":"10.3389\/fneur.2014.00250"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_053","doi-asserted-by":"crossref","unstructured":"Mazi, T.A., Shibata, N.M., and Medici, V. (2020). Lipid and energy metabolism in Wilson disease. Liver Res. 4: 5\u201314, https:\/\/doi.org\/10.1016\/j.livres.2020.02.002.","DOI":"10.1016\/j.livres.2020.02.002"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_054","doi-asserted-by":"crossref","unstructured":"Mchale-Owen, H., Faller, K.M.E., Chaytow, H., and Gillingwater, T.H. (2025). Phosphoglycerate kinase 1 as a therapeutic target in neurological disease. Trends. Mol. Med.","DOI":"10.1016\/j.molmed.2025.03.008"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_055","doi-asserted-by":"crossref","unstructured":"Meyer, P.T., Frings, L., R\u00fcCKER, G., and Hellwig, S. (2017). (18)F-FDG PET in parkinsonism: differential diagnosis and evaluation of cognitive impairment. J.\u00a0Nucl. Med. 58: 1888\u20131898, https:\/\/doi.org\/10.2967\/jnumed.116.186403.","DOI":"10.2967\/jnumed.116.186403"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_056","doi-asserted-by":"crossref","unstructured":"Miki, K., Yagi, M., Igami, K., Kittaka, H., Tani, A., Horiuchi, N., Fukumoto, S., Yoshimoto, K., and Uchiumi, T. (2025). Live-cell metabolic analyzer protocol for measuring glucose and lactate metabolic changes in human cells. STAR Protoc. 6: 103518, https:\/\/doi.org\/10.1016\/j.xpro.2024.103518.","DOI":"10.1016\/j.xpro.2024.103518"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_057","doi-asserted-by":"crossref","unstructured":"Minoshima, S., Cross, D., Thientunyakit, T., Foster, N.L., and Drzezga, A. (2022). (18)F-FDG PET imaging in neurodegenerative dementing disorders: insights into subtype classification, emerging disease categories, and mixed dementia with copathologies. J.\u00a0Nucl. Med. 63: 2s\u201312s, https:\/\/doi.org\/10.2967\/jnumed.121.263194.","DOI":"10.2967\/jnumed.121.263194"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_058","doi-asserted-by":"crossref","unstructured":"Mu\u00f1OZ de Le\u00f3N-L\u00f3PEZ, C.A., Navarro-Lobato, I., and Khan, Z.U. (2025). The role of astrocytes in synaptic dysfunction and memory deficits in Alzheimer\u2019s disease. Biomolecules 15.","DOI":"10.3390\/biom15070910"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_059","doi-asserted-by":"crossref","unstructured":"Muraleedharan, R. and Dasgupta, B. (2022). AMPK in the brain: its roles in glucose and neural metabolism. Feb. J. 289: 2247\u20132262, https:\/\/doi.org\/10.1111\/febs.16151.","DOI":"10.1111\/febs.16151"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_060","doi-asserted-by":"crossref","unstructured":"Muraleedharan, R., Gawali, M.V., Tiwari, D., Sukumaran, A., Oatman, N., Anderson, J., Nardini, D., Bhuiyan, M.A.N., Tk\u00e1\u010c, I., Ward, A.L., et al.. (2020). AMPK-regulated astrocytic lactate shuttle plays a non-cell-autonomous role in neuronal survival. Cell Rep. 32: 108092, https:\/\/doi.org\/10.1016\/j.celrep.2020.108092.","DOI":"10.1016\/j.celrep.2020.108092"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_061","doi-asserted-by":"crossref","unstructured":"Naeem, U., Arshad, A.R., Jawed, A., Eqbal, F., Imran, L., Khan, Z., and Ijaz, F. (2022). Glycolysis: the next big breakthrough in Parkinson\u2019s disease. Neurotox Res. 40: 1707\u20131717, https:\/\/doi.org\/10.1007\/s12640-022-00579-3.","DOI":"10.1007\/s12640-022-00579-3"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_062","doi-asserted-by":"crossref","unstructured":"Nambron, R., Silajd\u017ei\u0107, E., Kalliolia, E., Ottolenghi, C., Hindmarsh, P., Hill, N.R., Costelloe, S.J., Martin, N.G., Positano, V., Watt, H.C., et al.. (2016). A metabolic study of Huntington\u2019s disease. PLoS One 11: e0146480, https:\/\/doi.org\/10.1371\/journal.pone.0146480.","DOI":"10.1371\/journal.pone.0146480"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_063","doi-asserted-by":"crossref","unstructured":"Narine, M. and Colognato, H. (2022). Current insights into oligodendrocyte metabolism and its power to sculpt the Myelin landscape. Front. Cell Neurosci. 16: 892968, https:\/\/doi.org\/10.3389\/fncel.2022.892968.","DOI":"10.3389\/fncel.2022.892968"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_064","doi-asserted-by":"crossref","unstructured":"Nemkov, T., Stephenson, D., Earley, E.J., Keele, G.R., Hay, A., Key, A., Haiman, Z.B., Erickson, C., Dzieciatkowska, M., Reisz, J.A., et al.. (2024). Biological and genetic determinants of glycolysis: phosphofructokinase isoforms boost energy status of stored red blood cells and transfusion outcomes. Cell Metab. 36: 1979\u20131997.e13, https:\/\/doi.org\/10.1016\/j.cmet.2024.06.007.","DOI":"10.1016\/j.cmet.2024.06.007"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_065","doi-asserted-by":"crossref","unstructured":"Nijland, P.G., Molenaar, R.J., van der Pol, S.M., van der Valk, P., van Noorden, C.J., de Vries, H.E., and van Horssen, J. (2015). Differential expression of glucose-metabolizing enzymes in multiple sclerosis lesions. Acta Neuropathol. Commun. 3: 79, https:\/\/doi.org\/10.1186\/s40478-015-0261-8.","DOI":"10.1186\/s40478-015-0261-8"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_066","doi-asserted-by":"crossref","unstructured":"Pahlke, S., Kahale, L.A., Mahinrad, S., Sousa-Pinto, B., Vieira, R.J., Mcateer, M.B., Claessen, T., Contador, J., Hofmann, A., Kuchenbecker, L.A., et al.. (2025). Blood-based biomarkers for detecting Alzheimer\u2019s disease pathology in cognitively impaired individuals within specialized care settings: a systematic review and meta-analysis. Alzheimers Dement 21: e70828, https:\/\/doi.org\/10.1002\/alz.70828.","DOI":"10.1002\/alz.70828"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_067","doi-asserted-by":"crossref","unstructured":"Pan, R.Y., He, L., Zhang, J., Liu, X., Liao, Y., Gao, J., Liao, Y., Yan, Y., Li, Q., Zhou, X., et al. (2022). Positive feedback regulation of microglial glucose metabolism by histone H4 lysine 12 lactylation in Alzheimer\u2019s disease. Cell Metab. 34: 634\u2013648.e6, https:\/\/doi.org\/10.1016\/j.cmet.2022.02.013.","DOI":"10.1016\/j.cmet.2022.02.013"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_068","doi-asserted-by":"crossref","unstructured":"Park, S.J. and Choi, J.W. (2020). Brain energy metabolism and multiple sclerosis: progress and prospects. Arch. Pharm. Res. 43: 1017\u20131030, https:\/\/doi.org\/10.1007\/s12272-020-01278-3.","DOI":"10.1007\/s12272-020-01278-3"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_069","doi-asserted-by":"crossref","unstructured":"Park, E., He, C., Abbasi, A.Z., Tian, M., Huang, S., Wang, L., Georgiou, J., Collingridge, G.L., Fraser, P.E., Henderson, J.T., et al.. (2025). Brain microenvironment-remodeling nanomedicine improves cerebral glucose metabolism, mitochondrial activity and synaptic function in a mouse model of Alzheimer\u2019s disease. Biomaterials 318: 123142, https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123142.","DOI":"10.1016\/j.biomaterials.2025.123142"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_070","doi-asserted-by":"crossref","unstructured":"Pokotylo, M., Br\u00fcggemann, N., and Prasuhn, J. (2025). Metabolic dysregulation in Parkinson\u2019s disease: non-oxidative phosphorylation and its role in brain energy metabolism. Aging Dis. 16: 2721\u20132738, https:\/\/doi.org\/10.14336\/AD.2025.0619.","DOI":"10.14336\/AD.2025.0619"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_071","doi-asserted-by":"crossref","unstructured":"Polyzos, A.A., Lee, D.Y., Datta, R., Hauser, M., Budworth, H., Holt, A., Mihalik, S., Goldschmidt, P., Frankel, K., Trego, K., et al. (2019). Metabolic reprogramming in astrocytes distinguishes region-specific neuronal susceptibility in Huntington mice. Cell Metab. 29: 1258\u20131273.e11, https:\/\/doi.org\/10.1016\/j.cmet.2019.03.004.","DOI":"10.1016\/j.cmet.2019.03.004"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_072","doi-asserted-by":"crossref","unstructured":"Quintero, M.E., Pontes, J.G.M., and Tasic, L. (2021). Metabolomics in degenerative brain diseases. Brain Res. 1773: 147704, https:\/\/doi.org\/10.1016\/j.brainres.2021.147704.","DOI":"10.1016\/j.brainres.2021.147704"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_073","doi-asserted-by":"crossref","unstructured":"Ribeiro, G., Rodrigues, F.R., Pasqualotto, E., Dantas, J.M., and Di Luca, D.G. (2024). Exposure to glycolysis-enhancing drugs and risk of Parkinson\u2019s disease: a meta-analysis. J.\u00a0Parkinsons Dis. 14: 1237\u20131242, https:\/\/doi.org\/10.3233\/jpd-240104.","DOI":"10.3233\/JPD-240104"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_074","doi-asserted-by":"crossref","unstructured":"Rinholm, J.E., Hamilton, N.B., Kessaris, N., Richardson, W.D., Bergersen, L.H., and Attwell, D. (2011). Regulation of oligodendrocyte development and myelination by glucose and lactate. J.\u00a0Neurosci. 31: 538\u2013548, https:\/\/doi.org\/10.1523\/jneurosci.3516-10.2011.","DOI":"10.1523\/JNEUROSCI.3516-10.2011"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_075","doi-asserted-by":"crossref","unstructured":"Rodriguez-Rodriguez, P., Fernandez, E., Almeida, A., and Bola\u00f1OS, J.P. (2012). Excitotoxic stimulus stabilizes PFKFB3 causing pentose-phosphate pathway to glycolysis switch and neurodegeneration. Cell Death Differ. 19: 1582\u20131589, https:\/\/doi.org\/10.1038\/cdd.2012.33.","DOI":"10.1038\/cdd.2012.33"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_076","doi-asserted-by":"crossref","unstructured":"Ross, C.A. and Tabrizi, S.J. (2011). Huntington\u2019s disease: from molecular pathogenesis to clinical treatment. Lancet Neurol. 10: 83\u201398, https:\/\/doi.org\/10.1016\/s1474-4422(10)70245-3.","DOI":"10.1016\/S1474-4422(10)70245-3"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_077","doi-asserted-by":"crossref","unstructured":"Ruiz, L.M., Libedinsky, A., and Elorza, A.A. (2021). Role of copper on mitochondrial function and metabolism. Front. Mol. Biosci. 8: 711227, https:\/\/doi.org\/10.3389\/fmolb.2021.711227.","DOI":"10.3389\/fmolb.2021.711227"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_078","doi-asserted-by":"crossref","unstructured":"Saab, A.S., Tzvetavona, I.D., Trevisiol, A., Baltan, S., Dibaj, P., Kusch, K., M\u00f6BIUS, W., Goetze, B., Jahn, H.M., Huang, W., et al.. (2016). Oligodendroglial NMDA receptors regulate glucose import and axonal energy metabolism. Neuron 91: 119\u2013132, https:\/\/doi.org\/10.1016\/j.neuron.2016.05.016.","DOI":"10.1016\/j.neuron.2016.05.016"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_079","doi-asserted-by":"crossref","unstructured":"Sarode, G.V., Kim, K., Kieffer, D.A., Shibata, N.M., Litwin, T., Czlonkowska, A., and Medici, V. (2019). Metabolomics profiles of patients with Wilson disease reveal a distinct metabolic signature. Metabolomics 15: 43, https:\/\/doi.org\/10.1007\/s11306-019-1505-6.","DOI":"10.1007\/s11306-019-1505-6"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_080","doi-asserted-by":"crossref","unstructured":"Shen, J., Yao, E., Tian, W., He, J., Gu, Y., and Zhao, D. (2025). Glycolytic pathways: the hidden regulators in Parkinson\u2019s disease. Heliyon 11: e41831, https:\/\/doi.org\/10.1016\/j.heliyon.2025.e41831.","DOI":"10.1016\/j.heliyon.2025.e41831"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_081","doi-asserted-by":"crossref","unstructured":"Singh, A. and Agrawal, N. (2022). Metabolism in Huntington\u2019s disease: a major contributor to pathology. Metab. Brain Dis. 37: 1757\u20131771, https:\/\/doi.org\/10.1007\/s11011-021-00844-y.","DOI":"10.1007\/s11011-021-00844-y"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_082","doi-asserted-by":"crossref","unstructured":"Smusz, J., Mojsak, P., Matys, P., Miro\u0144czuk, A., Tarasiuk, J., Grubczak, K., Starosz, A., Kochanowicz, J., Ku\u0142akowska, A., Ruszczy\u0144ska, K., et al.. (2025). Metabolomics in multiple sclerosis: advances, challenges, and clinical Perspectives-A systematic review. Int. J.\u00a0Mol. Sci. 26, https:\/\/doi.org\/10.3390\/ijms26189207.","DOI":"10.3390\/ijms26189207"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_083","doi-asserted-by":"crossref","unstructured":"Sun, Y., Wang, Y., Chen, S.T., Chen, Y.J., Shen, J., Yao, W.B., Gao, X.D., and Chen, S. (2020). Modulation of the astrocyte-neuron lactate shuttle system contributes to neuroprotective action of fibroblast growth factor 21. Theranostics 10: 8430\u20138445, https:\/\/doi.org\/10.7150\/thno.44370.","DOI":"10.7150\/thno.44370"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_084","doi-asserted-by":"crossref","unstructured":"Tang, B.L. (2020). Glucose, glycolysis, and neurodegenerative diseases. J.\u00a0Cell. Physiol. 235: 7653\u20137662, https:\/\/doi.org\/10.1002\/jcp.29682.","DOI":"10.1002\/jcp.29682"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_085","doi-asserted-by":"crossref","unstructured":"Tefera, T.W., Steyn, F.J., Ngo, S.T., and Borges, K. (2021). CNS glucose metabolism in amyotrophic lateral sclerosis: a therapeutic target? Cell Biosci. 11: 14, https:\/\/doi.org\/10.1186\/s13578-020-00511-2.","DOI":"10.1186\/s13578-020-00511-2"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_086","doi-asserted-by":"crossref","unstructured":"Temple, S. (2023). Advancing cell therapy for neurodegenerative diseases. Cell Stem Cell 30: 512\u2013529, https:\/\/doi.org\/10.1016\/j.stem.2023.03.017.","DOI":"10.1016\/j.stem.2023.03.017"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_087","doi-asserted-by":"crossref","unstructured":"Thientunyakit, T., Muangpaisan, W., and Minoshima, S. (2025). 18F-FDG PET for dementia evaluation: co-pathologies, new diseases, and its roles in the era of antiamyloid treatment. Seminars Nucl. Med. 55: 526\u2013537, https:\/\/doi.org\/10.1053\/j.semnuclmed.2025.04.007.","DOI":"10.1053\/j.semnuclmed.2025.04.007"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_088","doi-asserted-by":"crossref","unstructured":"Verma, K.K., Gaur, P.K., Gupta, S.L., Lata, K., Kaushik, R., and Sharma, V. (2025). Metabolomics: a new Frontier in neurodegenerative disease biomarker discovery. Metabolomics 21: 67, https:\/\/doi.org\/10.1007\/s11306-025-02267-7.","DOI":"10.1007\/s11306-025-02267-7"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_089","doi-asserted-by":"crossref","unstructured":"Wang, A., Zou, Y., Liu, S., Zhang, X., Li, T., Zhang, L., Wang, R., Xia, Y., Li, X., Zhang, Z., et al. (2024). Comprehensive multiscale analysis of lactate metabolic dynamics in\u00a0vitro and in\u00a0vivo using highly responsive biosensors. Nat. Protoc. 19: 1311\u20131347, https:\/\/doi.org\/10.1038\/s41596-023-00948-y.","DOI":"10.1038\/s41596-023-00948-y"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_090","doi-asserted-by":"crossref","unstructured":"Watkins, B.A., Smith, B.J., Volpe, S.L., and Shen, C.L. (2024). Exerkines, nutrition, and systemic metabolism. Nutrients 16, https:\/\/doi.org\/10.3390\/nu16030410.","DOI":"10.3390\/nu16030410"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_091","doi-asserted-by":"crossref","unstructured":"Westeneng, H.J., Nitert, A.D., van Veenhuijzen, K., Wismans, C., Donatelli, G., Tan, H.H.G., van Hoek, W., van Es, M.A., Klomp, D.W.J., Bhogal, A.A., et al.. (2025). Patterns of altered in\u00a0vivo brain metabolism in patients with amyotrophic lateral sclerosis (ALS) and asymptomatic C9orf72 mutation carriers: a cross-sectional (1)H and (31)P magnetic resonance spectroscopic 7T imaging study. EBioMedicine 121: 105963, https:\/\/doi.org\/10.1016\/j.ebiom.2025.105963.","DOI":"10.1016\/j.ebiom.2025.105963"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_092","doi-asserted-by":"crossref","unstructured":"Wilson, D.M., Cookson, M.R., van Den Bosch, L., Zetterberg, H., Holtzman, D.M., and Dewachter, I. (2023). Hallmarks of neurodegenerative diseases. Cell 186: 693\u2013714, https:\/\/doi.org\/10.1016\/j.cell.2022.12.032.","DOI":"10.1016\/j.cell.2022.12.032"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_093","doi-asserted-by":"crossref","unstructured":"Woo, M.S., Brand, J., Bal, L.C., Moritz, M., Walkenhorst, M., Vieira, V., Ipenberg, I., Rothammer, N., Wang, M., Dogan, B., et al.s (2025). The immunoproteasome disturbs neuronal metabolism and drives neurodegeneration in multiple sclerosis. Cell 188: 4567\u20134585.e32, https:\/\/doi.org\/10.1016\/j.cell.2025.09.019.","DOI":"10.1016\/j.cell.2025.05.029"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_094","doi-asserted-by":"crossref","unstructured":"Yang, X., Chen, Y.H., Liu, L., Gu, Z., You, Y., Hao, J.R., Sun, N., and Gao, C. (2024). Regulation of glycolysis-derived L-lactate production in astrocytes rescues the memory deficits and A\u03b2 burden in early Alzheimer\u2019s disease models. Pharmacol. Res. 208: 107357, https:\/\/doi.org\/10.1016\/j.phrs.2024.107357.","DOI":"10.1016\/j.phrs.2024.107357"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_095","doi-asserted-by":"crossref","unstructured":"Yang, Z., Cummings, J.L., Kinney, J.W., and Cordes, D. (2023). Accelerated hypometabolism with disease progression associated with faster cognitive decline among amyloid positive patients. Front Neurosci. 17: 1151820, https:\/\/doi.org\/10.3389\/fnins.2023.1151820.","DOI":"10.3389\/fnins.2023.1151820"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_096","doi-asserted-by":"crossref","unstructured":"Yang, Y., Wu, J., Wang, L., Ji, G. and Dang, Y. (2024). Copper homeostasis\u00a0and cuproptosis in health and disease. Med. Comm. (2020). 5, e724, https:\/\/doi.org\/10.1002\/mco2.724.","DOI":"10.1002\/mco2.724"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_097","doi-asserted-by":"crossref","unstructured":"Zahoor, I., Rui, B., Khan, J., Datta, I., and Giri, S. (2021). An emerging potential of metabolomics in multiple sclerosis: a comprehensive overview. Cell. Mol. Life Sci. 78: 3181\u20133203, https:\/\/doi.org\/10.1007\/s00018-020-03733-2.","DOI":"10.1007\/s00018-020-03733-2"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_098","doi-asserted-by":"crossref","unstructured":"Zhang, X., Alshakhshir, N., and Zhao, L. (2021). Glycolytic metabolism, brain resilience, and Alzheimer\u2019s disease. Front. Neurosci. 15: 662242, https:\/\/doi.org\/10.3389\/fnins.2021.662242.","DOI":"10.3389\/fnins.2021.662242"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_099","doi-asserted-by":"crossref","unstructured":"Zhang, Y.M., Qi, Y.B., Gao, Y.N., Chen, W.G., Zhou, T., Zang, Y., and Li, J. (2023). Astrocyte metabolism and signaling pathways in the CNS. Front. Neurosci. 17: 1217451, https:\/\/doi.org\/10.3389\/fnins.2023.1217451.","DOI":"10.3389\/fnins.2023.1217451"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_100","doi-asserted-by":"crossref","unstructured":"Zhong, X., Gu, H., Lim, J., Zhang, P., Wang, G., Zhang, K., and Li, X. (2025). Genetically encoded sensors illuminate in\u00a0vivo detection for neurotransmission: development, application, and optimization strategies. IBRO Neurosci. Rep. 18: 476\u2013490, https:\/\/doi.org\/10.1016\/j.ibneur.2025.03.003.","DOI":"10.1016\/j.ibneur.2025.03.003"},{"key":"2026080410023542744_j_revneuro-2026-0037_ref_101","doi-asserted-by":"crossref","unstructured":"Zhou, W., Yang, X., Wang, H., Yao, W., Chu, D., and Wu, F. (2024). Neuronal aerobic glycolysis exacerbates synapse loss in aging mice. Exp. Neurol. 371: 114590, https:\/\/doi.org\/10.1016\/j.expneurol.2023.114590.","DOI":"10.1016\/j.expneurol.2023.114590"}],"container-title":["Reviews in the Neurosciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/revneuro-2026-0037\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/revneuro-2026-0037\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T10:03:54Z","timestamp":1785837834000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/revneuro-2026-0037\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,23]]},"references-count":101,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,4,23]]},"published-print":{"date-parts":[[2026,8,24]]}},"alternative-id":["10.1515\/revneuro-2026-0037"],"URL":"https:\/\/doi.org\/10.1515\/revneuro-2026-0037","relation":{},"ISSN":["0334-1763","2191-0200"],"issn-type":[{"value":"0334-1763","type":"print"},{"value":"2191-0200","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,23]]}}}